Transcranial magnetic stimulation intervention in Alzheimer's disease: a research proposal for a randomized controlled trial.
Elena M MarronRaquel Viejo-SoberaMaría QuintanaDiego Redolar-RipollDaniel RodríguezMaite GaroleraPublished in: BMC research notes (2018)
We expect to demonstrate that personalized TMS intervention has a measurable positive impact in cognition, emotion, daily living activities and brain connectivity, thus representing a potential treatment for Alzheimer's disease. Trial registration The trial has been prospectively registered at ClinicalTrials.gov, identifier NCT03121066. Date of registration: 04/19/2017.
Keyphrases
- transcranial magnetic stimulation
- high frequency
- white matter
- randomized controlled trial
- study protocol
- phase iii
- resting state
- cognitive decline
- clinical trial
- phase ii
- autism spectrum disorder
- physical activity
- mild cognitive impairment
- depressive symptoms
- blood brain barrier
- human health
- cerebral ischemia
- double blind
- replacement therapy